SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aimmune Therapeutics, Inc. – ‘SC 14D9’ on 9/14/20 re: Aimmune Therapeutics, Inc.

On:  Monday, 9/14/20, at 5:27pm ET   ·   Accession #:  1193125-20-245325   ·   File #:  5-88972

Previous ‘SC 14D9’:  None   ·   Next:  ‘SC 14D9/A’ on 9/21/20   ·   Latest:  ‘SC 14D9/A’ on 10/13/20   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/14/20  Aimmune Therapeutics, Inc.        SC 14D9                2:676K Aimmune Therapeutics, Inc.        Donnelley … Solutions/FA

Tender-Offer Solicitation/Recommendation Statement   —   Sch. 14D-9
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 14D9     Tender-Offer Solicitation/Recommendation Statement  HTML    481K 
 2: EX-99.(A)(13)  Miscellaneous Exhibit                            HTML      8K 




        
Filing Submission 0001193125-20-245325 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 676K                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20200914-172805	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20200914-172802	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20200914-172729	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001193125-20-245325
<TYPE>				SC 14D9
<PUBLIC-DOCUMENT-COUNT>		4
<FILING-DATE>			20200914
<DATE-OF-FILING-DATE-CHANGE>	20200914
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>		Aimmune Therapeutics, Inc.
<CIK>				0001631650
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			452748244  45-2748244 or 452-74-8244
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 14D9
<ACT>				34
<FILE-NUMBER>			005-88972
<FILM-NUMBER>			201174029
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			8000 MARINA BOULEVARD
<STREET2>			SUITE 300
<CITY>				BRISBANE
<STATE>				CA
<ZIP>				94005-1884
<PHONE>				(650) 614-5220
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			8000 MARINA BOULEVARD
<STREET2>			SUITE 300
<CITY>				BRISBANE
<STATE>				CA
<ZIP>				94005-1884
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Allergen Research Corp
<DATE-CHANGED>			20150123
</FORMER-COMPANY>
</SUBJECT-COMPANY>
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>		Aimmune Therapeutics, Inc.
<CIK>				0001631650
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			452748244  45-2748244 or 452-74-8244
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 14D9
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			8000 MARINA BOULEVARD
<STREET2>			SUITE 300
<CITY>				BRISBANE
<STATE>				CA
<ZIP>				94005-1884
<PHONE>				(650) 614-5220
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			8000 MARINA BOULEVARD
<STREET2>			SUITE 300
<CITY>				BRISBANE
<STATE>				CA
<ZIP>				94005-1884
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Allergen Research Corp
<DATE-CHANGED>			20150123
</FORMER-COMPANY>
</FILED-BY>
<DOCUMENT>
<TYPE>		SC 14D9
<SEQUENCE>	1
<FILENAME>	d35008dsc14d9.htm
<DESCRIPTION>	SC 14D9
<TEXT>
<HTML>
       Show <HTML>: 6,804 lines (widest: 253 characters) - 627K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-99.(A)(13)
<SEQUENCE>	2
<FILENAME>	d35008dex99a13.htm
<DESCRIPTION>	EX-99.(A)(13)
<TEXT>
<HTML>
       Show <HTML>: 49 lines (widest: 249 characters) - 6K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	3  Not a Document/Exhibit
<FILENAME>	g35008g01f82.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 533 lines (Unix-to-Unix encoding) - 33K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	4  Not a Document/Exhibit
<FILENAME>	g35008g0912093518768.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 169 lines (Unix-to-Unix encoding) - 11K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0001193125-20-245325   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:41:25.3pm ET